Member Info for Elsol

Do I read this correct 30 Tonnes of this stuff has been shipped to ITX?
Cannot be R&D volume so must be a client instruction I'm guessing. So what do our BB chemists think is most probable? Mixing with an ITX ingredient to trial out x% eco with y% of original carbon based ingredient. Maybe a preliminary production run of something to verify scale production? Could be interesting

Interesting. Certainly may help in new viral outbreak zones that have also largely been ring fenced. Eg could have been used in Wuhan if available then. Could slow spread and dampen the spread to contain the outbreak.f

Good one fruits. My theory is that people over 40 strongly discourage under age sex and by Darwinian hypotheses, drive down the reproduction number significantly in the more virile segment of humans. ?? . So it's nature's way of pushing the old foggies off the planet...

It's a good job for SNG that adults no longer have this super turbo interferon response.....BUT why on earth did natural selection do away with such a good early antiviral defence as we mature? Very odd, nature threw away something that worked. Strange genetic nuance of life

Is the right time when we have stat. Sig. data? Or are you able to do a write up Andy now?

Ditto. Good effort all.

You two are living in a very tiny box of mental conditioning have totally accepted human norms of a largely predictable world. If a large catastrophic meteorite was headed towards a direct strike on earth likely to cause extinction of mankind, would you (a) launch a largely untested ballistic missile to give a 40% chance to avoid that outcome by redirecting the meteorite onto a near miss trajectory; or, (b) advise to do more research on the missile system to make sure it was absolutely accurate with 95% confidence limits and risk the event by running short on time to prevent the impact. Go work it out. Pragmatism and flexibility beats mental pre-conditioning...obviously you both don't appreciate risk and reward very well.

Ndn71. I beg to differ. If covid kill rate was nearer 10% of all infected as it could have been then EA would have been the only option for mankind. Eg. Real world evidence of efficacy vs small chance of adverse events. So my question is what death rate qualifies for an EA for a lower death rate? ?? Go and ask the dead...

It's good news if the "riskies" have a siRNA with good efficacy. Its a bit behind us in time to market but may have a role to play in fighting covid. However, it will not work with further big mutations and into other viruses like RSV. Influenza and SNG001 probably will.

Mutations are random in the virus genome so it could get less severe or more severe as it evolves. Its a bit like flu now...

Just re-pasting Brand's good post below - SNG would fit perfectly in AZN respiratory franchise since they also have Influenza and RSV candidates (complementary/[SNG is a threat to these too]):

https://www.fiercepharma.com/pharma/astrazeneca-weighs-spinning-division-covid-19-vaccine-antibodies-into-separate-company

Separating the business would be an answer to earlier concerns that tapping into COVID-19 might have been a distraction for the company. But senior executives are evaluating various possibilities with advisers and could eventually decide against a spinoff, the people said, according to the news service.

AZ unveiled the new division a month ago. To be led by Iskra Reic, AZ’s executive vice president of Europe and Canada, the new unit is basically a viral respiratory infectious disease franchise. It houses the company’s COVID-19 vaccine Vaxzevria and investigational COVID antibody ****tail AZD7442 plus nasal spray flu vaccine Flumist, ex-U.S. rights to respiratory syncytial virus (RSV) drug Synagis and an investigational RSV therapy called nirsevimab that’s partnered with Sanofi.

That was a bit out of the blue - demand pull at work. Interesting new channel to market and potentially quite big if it takes off well as a new ECO fashion trend since others will likely want to follow.

I think it would be too embarrassing for AZ to let this one go after the prior R&D agreement was closed down early...

I think it would be too embarrassing for AZ to let this one go after the prior R&D agreement was closed down early...

Its a perfect marriage a seller a buyer.....AZN have them now. Quietly

Deepfek I think 10p is about right. I was assuming 12p by year end but let's see

Doc83 thx for your informative note.

Does it indicate that the virus mutates and evolves quicker than our molecular medicine based innovation of drugs against it. ...no brainer covid is doing this - its an RNA virus!

Timing tells me its year end bonus time for Polar 's management team they need to book some profit.

thanks wacca LOL - probably now all the bigger blue chip customers are going to increase there stock levels so I think we are in for a bumper Q1 and Q2